Genetic variability of hepatitis C virus before and after combined therapy of interferon plus ribavirin.

ABSTRACT: We present an analysis of the selective forces acting on two hepatitis C virus genome regions previously postulated to be involved in the viral response to combined antiviral therapy. One includes the three hypervariable regions in the envelope E2 glycoprotein, and the other encompasses the PKR binding domain and the V3 domain in the NS5A region. We used a cohort of 22 non-responder patients to combined therapy (interferon alpha-2a plus ribavirin) for which samples were obtained before initiation of therapy and after 6 or/and 12 months of treatment. A range of 25-100 clones per patient, genome region and time sample were sequenced. These were used to detect general patterns of adaptation, to identify particular adaptation mechanisms and to analyze the patterns of evolutionary change in bot

SUBMITTER: Cuevas JM 

PROVIDER: S-EPMC2518109 | biostudies-literature | 2008 Aug

REPOSITORIES: biostudies-literature